Cargando…

Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review

INTRODUCTION AND IMPORTANCE: To describe an unusual case with a primary hepatic neuroendocrine tumour (PHNET) with multiple liver metastases. CASE PRESENTATION: We reported a 65-year-old woman with PHNET with multiple liver metastases. She was highly suspected of having primary liver cancer with mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wei-Ming, Li, Ri, Sun, Bing-Lun, Du, Ji-Kang, Tuo, Hong-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591487/
https://www.ncbi.nlm.nih.gov/pubmed/34784532
http://dx.doi.org/10.1016/j.ijscr.2021.106590
_version_ 1784599246149779456
author Yu, Wei-Ming
Li, Ri
Sun, Bing-Lun
Du, Ji-Kang
Tuo, Hong-Fang
author_facet Yu, Wei-Ming
Li, Ri
Sun, Bing-Lun
Du, Ji-Kang
Tuo, Hong-Fang
author_sort Yu, Wei-Ming
collection PubMed
description INTRODUCTION AND IMPORTANCE: To describe an unusual case with a primary hepatic neuroendocrine tumour (PHNET) with multiple liver metastases. CASE PRESENTATION: We reported a 65-year-old woman with PHNET with multiple liver metastases. She was highly suspected of having primary liver cancer with multiple intrahepatic metastases before liver biopsy, but was diagnosed with PHNET with multiple liver metastases after histopathology and immunohistochemistry (IHC) examinations. The patient successfully underwent three times of transcatheter arterial chemoembolization (TACE), and is currently living in a good state without related complications. CLINICAL DISCUSSION: Neuroendocrine tumors (NETs), also known as carcinoids or argyrophilic tumors, are very rare malignant tumors. The liver is the main metastasis site of NETs, but primary hepatic neuroendocrine tumors (PHNETs) are extremely rare. Histopathology and immunohistochemistry (IHC) examinations are still the main methods used for diagnosing NETs. There are no treatment guidelines for PHNETs, and surgical resection is generally the preferred treatment. For PHNET patients who are not suitable for surgery, TACE has been proven to be an effective alternative treatment that can effectively reduce the tumour burden and relieve symptoms, but the current evidence is still limited. CONCLUSION: The clinical diagnosis of PHNET still faces great challenges, imaging examinations often lead to misdiagnosis, and its diagnosis mainly depends on histopathology and immunohistochemical examinations. For PHNET patients who are not suitable for surgery, TACE may be an effective alternative therapy.
format Online
Article
Text
id pubmed-8591487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85914872021-11-22 Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review Yu, Wei-Ming Li, Ri Sun, Bing-Lun Du, Ji-Kang Tuo, Hong-Fang Int J Surg Case Rep Case Report INTRODUCTION AND IMPORTANCE: To describe an unusual case with a primary hepatic neuroendocrine tumour (PHNET) with multiple liver metastases. CASE PRESENTATION: We reported a 65-year-old woman with PHNET with multiple liver metastases. She was highly suspected of having primary liver cancer with multiple intrahepatic metastases before liver biopsy, but was diagnosed with PHNET with multiple liver metastases after histopathology and immunohistochemistry (IHC) examinations. The patient successfully underwent three times of transcatheter arterial chemoembolization (TACE), and is currently living in a good state without related complications. CLINICAL DISCUSSION: Neuroendocrine tumors (NETs), also known as carcinoids or argyrophilic tumors, are very rare malignant tumors. The liver is the main metastasis site of NETs, but primary hepatic neuroendocrine tumors (PHNETs) are extremely rare. Histopathology and immunohistochemistry (IHC) examinations are still the main methods used for diagnosing NETs. There are no treatment guidelines for PHNETs, and surgical resection is generally the preferred treatment. For PHNET patients who are not suitable for surgery, TACE has been proven to be an effective alternative treatment that can effectively reduce the tumour burden and relieve symptoms, but the current evidence is still limited. CONCLUSION: The clinical diagnosis of PHNET still faces great challenges, imaging examinations often lead to misdiagnosis, and its diagnosis mainly depends on histopathology and immunohistochemical examinations. For PHNET patients who are not suitable for surgery, TACE may be an effective alternative therapy. Elsevier 2021-11-12 /pmc/articles/PMC8591487/ /pubmed/34784532 http://dx.doi.org/10.1016/j.ijscr.2021.106590 Text en © 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Yu, Wei-Ming
Li, Ri
Sun, Bing-Lun
Du, Ji-Kang
Tuo, Hong-Fang
Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review
title Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review
title_full Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review
title_fullStr Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review
title_full_unstemmed Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review
title_short Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review
title_sort primary hepatic neuroendocrine tumour with multiple liver metastases: a case report with literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591487/
https://www.ncbi.nlm.nih.gov/pubmed/34784532
http://dx.doi.org/10.1016/j.ijscr.2021.106590
work_keys_str_mv AT yuweiming primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview
AT liri primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview
AT sunbinglun primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview
AT dujikang primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview
AT tuohongfang primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview